Autoimmune Life Blog

Dr. Gerald (Jerry) Nepom, who founded BRI’s Diabetes Research Program in the 1980’s, and who led BRI’s growth as a world-class research institute for 3 decades, now devotes his time to a laser-focused effort on getting experimental therapies to patients.

BRI has made game-changing discoveries and significantly expanded our research and funding in recent years.

When type 1 diabetes (T1D) strikes, it impacts the whole family in every way imaginable, day and night, forever. For siblings, the changes that come when a sister or brother is diagnosed with T1D hit like an earthquake, sudden and seismic.

Winter is coming, brace yourself. While for many this means singing carols and enjoying the holiday lights, for those living with autoimmune diseases including type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and lupus, it can mean a flurry of concerns.

Type 1 diabetes (T1D) is an immensely complex disease, which means it’s going to take many minds—and many approaches—to conquer it. BRI plays a key role in this fight. Here are three ways we're using our expertise to improve research worldwide.

When Merry Malnar was 11 years old, her mom took her in for a routine physical and asked the doctor to test for type 1 diabetes (T1D). Merry seemed perfectly healthy, but T1D ran in the family and her mom feared Merry would inherit it too.

It might seem unlikely for scientists at Benaroya Research Institute at Virginia Mason (BRI), a research institute focused on causes and cures for autoimmune disease, to study cancer. Scientists like Dr.

Principal Investigator Karen Cerosaletti, PhD, and colleagues have applied single-cell science to better understand type 1 diabetes with some surprising and significant findings.

Benaroya Research Institute will celebrate eight years of partnership with the Boeing Classic at this year’s tournament on August 20-26.

Our family learned a lot about type 1 diabetes in the weeks after our son Peter was diagnosed just a few days before his third birthday.